 Brian Herrmann
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 4 | 2024 | 221 | 1.470 |
Why?
| | Sleep Apnea, Obstructive | 4 | 2024 | 293 | 1.340 |
Why?
| | Hearing Loss, Sensorineural | 3 | 2024 | 67 | 1.160 |
Why?
| | Adenoma, Pleomorphic | 2 | 2023 | 11 | 1.060 |
Why?
| | Haemophilus influenzae | 2 | 2024 | 63 | 1.050 |
Why?
| | Salivary Gland Neoplasms | 2 | 2023 | 41 | 1.030 |
Why?
| | Tympanoplasty | 2 | 2022 | 8 | 0.970 |
Why?
| | Tympanic Membrane Perforation | 2 | 2022 | 17 | 0.960 |
Why?
| | Olfaction Disorders | 2 | 2023 | 63 | 0.950 |
Why?
| | Palatine Tonsil | 2 | 2024 | 48 | 0.950 |
Why?
| | Meningitis, Bacterial | 2 | 2024 | 47 | 0.890 |
Why?
| | Child | 28 | 2025 | 21935 | 0.860 |
Why?
| | Meningitis, Haemophilus | 1 | 2023 | 6 | 0.850 |
Why?
| | Haemophilus Infections | 1 | 2024 | 42 | 0.850 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 5 | 0.840 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 6 | 0.840 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 166 | 0.840 |
Why?
| | Carcinoma, Acinar Cell | 1 | 2023 | 4 | 0.830 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 14 | 0.830 |
Why?
| | Parotid Neoplasms | 1 | 2023 | 16 | 0.830 |
Why?
| | Meningitis, Pneumococcal | 1 | 2023 | 7 | 0.820 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 98 | 0.820 |
Why?
| | Lymphadenopathy | 1 | 2022 | 10 | 0.800 |
Why?
| | Histiocytosis, Sinus | 1 | 2022 | 8 | 0.790 |
Why?
| | Tonsillectomy | 2 | 2021 | 89 | 0.790 |
Why?
| | Deafness | 1 | 2023 | 77 | 0.770 |
Why?
| | Adenoidectomy | 2 | 2021 | 72 | 0.710 |
Why?
| | Epidermal Cyst | 1 | 2020 | 11 | 0.680 |
Why?
| | Dermoid Cyst | 1 | 2020 | 15 | 0.680 |
Why?
| | Hearing Loss, Conductive | 4 | 2025 | 25 | 0.670 |
Why?
| | Mouth Diseases | 1 | 2020 | 45 | 0.660 |
Why?
| | Liposarcoma, Myxoid | 1 | 2019 | 10 | 0.630 |
Why?
| | Li-Fraumeni Syndrome | 1 | 2019 | 14 | 0.620 |
Why?
| | Septo-Optic Dysplasia | 1 | 2019 | 4 | 0.620 |
Why?
| | Facial Neoplasms | 1 | 2019 | 19 | 0.620 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 343 | 0.620 |
Why?
| | Retrospective Studies | 17 | 2025 | 15657 | 0.580 |
Why?
| | Databases, Factual | 1 | 2024 | 1357 | 0.570 |
Why?
| | Perception | 1 | 2021 | 359 | 0.570 |
Why?
| | Child, Preschool | 14 | 2025 | 11074 | 0.560 |
Why?
| | Infant | 11 | 2025 | 9465 | 0.530 |
Why?
| | Body Weight | 1 | 2021 | 985 | 0.510 |
Why?
| | Ear, Middle | 3 | 2024 | 85 | 0.490 |
Why?
| | Paranasal Sinus Diseases | 2 | 2005 | 15 | 0.480 |
Why?
| | Lymphoproliferative Disorders | 2 | 2005 | 57 | 0.460 |
Why?
| | Rhinitis | 2 | 2006 | 158 | 0.410 |
Why?
| | Male | 23 | 2025 | 67762 | 0.400 |
Why?
| | Otitis Media | 4 | 2024 | 165 | 0.390 |
Why?
| | Female | 23 | 2025 | 73304 | 0.390 |
Why?
| | Humans | 33 | 2025 | 137585 | 0.380 |
Why?
| | Lung Transplantation | 2 | 2005 | 313 | 0.380 |
Why?
| | Parents | 1 | 2021 | 1347 | 0.380 |
Why?
| | Middle Ear Ventilation | 2 | 2024 | 15 | 0.370 |
Why?
| | Hearing Loss, Bilateral | 2 | 2023 | 12 | 0.370 |
Why?
| | Head and Neck Neoplasms | 2 | 2005 | 606 | 0.310 |
Why?
| | Epidural Abscess | 2 | 2006 | 6 | 0.280 |
Why?
| | Tomography, X-Ray Computed | 5 | 2024 | 2691 | 0.280 |
Why?
| | Adolescent | 11 | 2025 | 21513 | 0.270 |
Why?
| | Sphenoid Sinusitis | 1 | 2006 | 5 | 0.260 |
Why?
| | Frontal Sinusitis | 1 | 2006 | 3 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 5 | 2020 | 3566 | 0.250 |
Why?
| | Blindness | 1 | 2006 | 38 | 0.250 |
Why?
| | Neck | 2 | 2022 | 101 | 0.250 |
Why?
| | Central Nervous System Infections | 1 | 2006 | 35 | 0.240 |
Why?
| | Mycoses | 1 | 2006 | 79 | 0.240 |
Why?
| | Ear Canal | 1 | 2025 | 15 | 0.240 |
Why?
| | Craniofacial Dysostosis | 1 | 2005 | 3 | 0.240 |
Why?
| | Audiometry | 1 | 2025 | 29 | 0.240 |
Why?
| | Smell | 2 | 2023 | 117 | 0.230 |
Why?
| | Ear, External | 1 | 2005 | 21 | 0.230 |
Why?
| | Ear | 1 | 2025 | 34 | 0.230 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2005 | 21 | 0.230 |
Why?
| | Lipoma | 1 | 2004 | 16 | 0.230 |
Why?
| | Turbinates | 1 | 2024 | 14 | 0.230 |
Why?
| | Fibroma | 1 | 2004 | 21 | 0.230 |
Why?
| | Empyema, Subdural | 1 | 2004 | 1 | 0.220 |
Why?
| | Congenital Abnormalities | 1 | 2025 | 92 | 0.220 |
Why?
| | Eustachian Tube | 1 | 2024 | 8 | 0.220 |
Why?
| | Endoscopes | 1 | 2024 | 17 | 0.220 |
Why?
| | Connective Tissue | 1 | 2004 | 36 | 0.220 |
Why?
| | Orbital Diseases | 1 | 2004 | 32 | 0.210 |
Why?
| | Transplants | 1 | 2004 | 36 | 0.210 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 83 | 0.210 |
Why?
| | Cleft Lip | 1 | 2024 | 52 | 0.210 |
Why?
| | Neuroblastoma | 1 | 2005 | 160 | 0.210 |
Why?
| | Parotid Gland | 1 | 2023 | 23 | 0.210 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2004 | 70 | 0.210 |
Why?
| | Nasal Mucosa | 1 | 2004 | 107 | 0.210 |
Why?
| | Cleft Palate | 1 | 2024 | 68 | 0.210 |
Why?
| | Submandibular Gland | 1 | 2023 | 20 | 0.210 |
Why?
| | Nose Neoplasms | 1 | 2003 | 25 | 0.200 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2003 | 28 | 0.200 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2023 | 42 | 0.200 |
Why?
| | Retropharyngeal Abscess | 1 | 2002 | 7 | 0.200 |
Why?
| | Vaccines, Conjugate | 1 | 2023 | 65 | 0.200 |
Why?
| | Hyperplasia | 1 | 2023 | 175 | 0.200 |
Why?
| | Nasal Cavity | 1 | 2003 | 52 | 0.200 |
Why?
| | Paclitaxel | 1 | 2004 | 230 | 0.200 |
Why?
| | Steroids | 1 | 2023 | 167 | 0.200 |
Why?
| | Rhabdomyosarcoma | 1 | 2003 | 72 | 0.190 |
Why?
| | Down-Regulation | 1 | 2024 | 657 | 0.190 |
Why?
| | Hearing | 1 | 2023 | 118 | 0.180 |
Why?
| | Pneumococcal Vaccines | 1 | 2023 | 142 | 0.180 |
Why?
| | Sinusitis | 1 | 2004 | 221 | 0.180 |
Why?
| | Streptococcus pneumoniae | 1 | 2023 | 169 | 0.180 |
Why?
| | Ranula | 1 | 2020 | 3 | 0.170 |
Why?
| | Mouth Floor | 1 | 2020 | 7 | 0.170 |
Why?
| | Sleep Apnea Syndromes | 1 | 2021 | 88 | 0.160 |
Why?
| | Stents | 1 | 2004 | 527 | 0.160 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2019 | 4 | 0.160 |
Why?
| | Collagen | 1 | 2022 | 452 | 0.160 |
Why?
| | Hearing Loss, Unilateral | 1 | 2019 | 5 | 0.150 |
Why?
| | Swine | 1 | 2022 | 775 | 0.150 |
Why?
| | Acoustic Impedance Tests | 1 | 2019 | 13 | 0.150 |
Why?
| | Perioperative Care | 1 | 2021 | 178 | 0.150 |
Why?
| | Heart Transplantation | 1 | 2005 | 754 | 0.150 |
Why?
| | RNA, Viral | 1 | 2022 | 656 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 1 | 2022 | 565 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2023 | 3556 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2002 | 363 | 0.140 |
Why?
| | Down Syndrome | 1 | 2023 | 496 | 0.130 |
Why?
| | Ultrasonography | 1 | 2020 | 759 | 0.130 |
Why?
| | Overweight | 1 | 2021 | 558 | 0.120 |
Why?
| | Prospective Studies | 3 | 2023 | 7604 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 762 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2021 | 601 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2022 | 10811 | 0.110 |
Why?
| | Biomarkers | 1 | 2024 | 4149 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.100 |
Why?
| | Chronic Disease | 1 | 2019 | 1793 | 0.100 |
Why?
| | Adult | 3 | 2024 | 37929 | 0.100 |
Why?
| | Acute Disease | 2 | 2006 | 1007 | 0.100 |
Why?
| | Body Mass Index | 1 | 2021 | 2389 | 0.090 |
Why?
| | Endoscopy | 2 | 2024 | 318 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5472 | 0.090 |
Why?
| | Pilot Projects | 2 | 2004 | 1710 | 0.070 |
Why?
| | Obesity | 1 | 2021 | 2992 | 0.070 |
Why?
| | Prevalence | 2 | 2024 | 2734 | 0.070 |
Why?
| | Sphenoid Sinus | 1 | 2006 | 11 | 0.060 |
Why?
| | Prognosis | 2 | 2005 | 4030 | 0.060 |
Why?
| | Adenoids | 1 | 2005 | 12 | 0.060 |
Why?
| | Congenital Microtia | 1 | 2025 | 7 | 0.060 |
Why?
| | Mastoid | 1 | 2005 | 13 | 0.060 |
Why?
| | Limb Deformities, Congenital | 1 | 2005 | 14 | 0.060 |
Why?
| | Audiometry, Pure-Tone | 1 | 2005 | 30 | 0.060 |
Why?
| | Cholesteatoma | 1 | 2005 | 10 | 0.060 |
Why?
| | Headache | 1 | 2006 | 147 | 0.060 |
Why?
| | Hypertrophy | 1 | 2005 | 133 | 0.060 |
Why?
| | Nasal Polyps | 1 | 2005 | 59 | 0.060 |
Why?
| | Nasal Obstruction | 1 | 2005 | 27 | 0.060 |
Why?
| | Nasal Septum | 1 | 2024 | 25 | 0.060 |
Why?
| | Constriction, Pathologic | 1 | 2025 | 245 | 0.060 |
Why?
| | Sheep, Domestic | 1 | 2004 | 34 | 0.050 |
Why?
| | Syndrome | 1 | 2005 | 358 | 0.050 |
Why?
| | Fascia | 1 | 2004 | 17 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 53 | 0.050 |
Why?
| | Coated Materials, Biocompatible | 1 | 2004 | 62 | 0.050 |
Why?
| | Abscess | 1 | 2004 | 75 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2004 | 189 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2005 | 6079 | 0.050 |
Why?
| | Odorants | 1 | 2023 | 109 | 0.050 |
Why?
| | Hypersensitivity | 1 | 2006 | 257 | 0.050 |
Why?
| | Random Allocation | 1 | 2004 | 353 | 0.050 |
Why?
| | Animals | 2 | 2022 | 36940 | 0.050 |
Why?
| | Lymph Nodes | 1 | 2005 | 491 | 0.050 |
Why?
| | Drainage | 1 | 2002 | 173 | 0.050 |
Why?
| | Thinness | 1 | 2021 | 91 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2023 | 549 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2004 | 1483 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1738 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1946 | 0.040 |
Why?
| | Weight Gain | 1 | 2021 | 519 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2757 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2005 | 5131 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2005 | 1114 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2004 | 4295 | 0.030 |
Why?
| | Risk Factors | 1 | 2004 | 10388 | 0.020 |
Why?
|
|
Herrmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|